EMSLR and urinary bladder carcinoma: As expected, T‐cell cytotoxicity assays using activated Jurkat T cells also validated that lncRNA BCCE4 significantly impaired the activity of cytotoxic T cells against bladder cancer cells (Figure S30B, Supporting Information).